Features | Partner Sites | Information | LinkXpress
Sign In
JIB
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING

Methodic Strategy Developed for 3D Tissue Engineering of Viable Organ Implants

By BiotechDaily International staff writers
Posted on 27 Aug 2013
Image: Confocal microscopy images showing the different levels of organization (Photo courtesy of Agency for Science, Technology and Research (A*STAR), Singapore).
Image: Confocal microscopy images showing the different levels of organization (Photo courtesy of Agency for Science, Technology and Research (A*STAR), Singapore).
Researchers in Singapore have developed a simple way to organize cells and their microenvironments in hydrogel fibers. Their novel technology provides a practical template for constructing complicated structures, such as liver and fat tissues.

The investigators published their findings August 19, 2013, in the journal Nature Communications. According to the Institute of Bioengineering and Nanotechnology (IBN; Singapore) executive director Prof. Jackie Y. Ying, “Our tissue engineering approach gives researchers great control and flexibility over the arrangement of individual cell types, making it possible to engineer prevascularized tissue constructs easily. This innovation brings us a step closer toward developing viable tissue or organ replacements.”

IBN team leader and lead research scientist, Dr. Andrew Wan, elaborated, “Critical to the success of an implant is its ability to rapidly integrate with the patient’s circulatory system. This is essential for the survival of cells within the implant, as it would ensure timely access to oxygen and essential nutrients, as well as the removal of metabolic waste products. Integration would also facilitate signaling between the cells and blood vessels, which is important for tissue development.”

Tissues designed with preformed vascular networks are known to foster rapid vascular integration with the host. Generally, prevascularization has been achieved by seeding or encapsulating endothelial cells, which line the interior surfaces of blood vessels, with other cell types. In many of these approaches, the eventual distribution of vessels within a thick structure is based on in vitro cellular infiltration and self-organization of the cell mixture. These are slow processes, frequently leading to a nonuniform network of vessels within the tissue. As vascular self-assembly requires a large concentration of endothelial cells, this technique also greatly restricts the number of other cells that may be co-cultured.

Alternatively, scientists have attempted to direct the distribution of newly formed vessels via three-dimensional (3D) co-patterning of endothelial cells with other cell types in a hydrogel. This approach allows large concentrations of endothelial cells to be placed in specific areas within the tissue, leaving the rest of the construct available for other cell types. The hydrogel also acts as a reservoir of nutrients for the encapsulated cells. However, co-patterning multiple cell types within a hydrogel is not easy. Traditional techniques, such as micromolding and organ printing, are limited by large volumes of cell suspension, slow cell assembly, complicated multistep processes, and costly instruments. These factors also make it difficult to scale up the production of implantable 3D cell-patterned constructs. Up to now, these strategies have not been able to achieve vascularization and mass transport through dense engineered tissues.

To overcome these hurdles, IBN researchers have used interfacial polyelectrolyte complexation (IPC) fiber assembly, a unique cell patterning technology patented by IBN, to generate cell-laden hydrogel fibers under aqueous conditions at room temperature. In contrast to other technology, IBN’s unique technique allows researchers to incorporate different cell types separately into different fibers, and these cell-laden fibers may then be assembled into more complex constructs with hierarchical tissue structures. Furthermore, IBN researchers are able to customize the microenvironment for each cell type for enhanced functionality by integrating the appropriate factors, e.g., proteins, into the fibers. Using IPC fiber assembly, the researchers have engineered an endothelial vessel network, as well as liver tissue constructs and cell-patterned fat, which have successfully integrated with the host circulatory system in a mouse model and produced vascularized tissues.

The IBN researchers are now working on applying and further developing their technology toward engineering functional tissues and clinical applications.

Related Links:
Institute of Bioengineering and Nanotechnology



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: A scheme for the generation of induced pluripotent stem cells (IPSC). (1) Isolate and culture donor cells. (2) Transfect stem cell-associated genes into the cells by viral vectors. Red cells indicate the cells expressing the exogenous genes. (3)  Harvest and culture the cells using mitotically inactivated feeder cells. (4) A small subset of the transfected cells forms iPSC cell colonies (Photo courtesy of Wikimedia Commons).

Innovative Technique Produces More Reliable Pluripotent Stem Cells

A recent paper described a more reliable way to induce the formation of pluripotent stem cells (iPSCs) from adult cells in a mouse model. Reliable high-quality iPSCs are needed for the development of... Read more

Drug Discovery

view channel
Image: S-649266 has more robust antibacterial activity than established antibiotics against multidrug-resistant bacteria (Photo courtesy of Shionogi).

Novel Antibiotic Shows Potential for Broad Range of Infections

The emergence of bacterial resistance to known antibacterial agents is becoming a major challenge in treating the infection caused by multi drug resistant (MDR) bacteria. In order to treat bacterial... Read more

Business

view channel

Collaboration of Mayo Clinic and IBM Cognitive Computer Devised to Improve Clinical Trial Research

The Mayo Clinic (Rochester, MN, USA) and IBM (Armonk, NY, USA) recently announced plans to pilot Watson, the IBM cognitive computer, to match patients more rapidly with suitable clinical trials. A proof-of-concept phase is currently ongoing, with the intent to introduce it into clinical use in early 2015.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.